Linked Life Data

11112678

Source:http://linkedlifedata.com/resource/pubmed/id/11112678

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11112678rdf:typepubmed:Citationlld:pubmed
pubmed-article:11112678lifeskim:mentionsumls-concept:C0003232lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C0015967lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C0060400lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C0549178lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C1880496lld:lifeskim
pubmed-article:11112678lifeskim:mentionsumls-concept:C2348205lld:lifeskim
pubmed-article:11112678pubmed:issue1lld:pubmed
pubmed-article:11112678pubmed:dateCreated2001-1-29lld:pubmed
pubmed-article:11112678pubmed:abstractTextEmpiric oral antibiotic therapy for febrile neutropenic cancer patients has been suggested as a means to decrease hospitalization, but the safety of this approach has not been adequately studied in children. We compared continued iv antibiotic therapy with switching treatment to orally administered cefixime in a group of selected febrile neutropenic children for whom blood cultures were sterile after 48 h of incubation. Two hundred episodes of febrile neutropenia were studied (156 patients), and 100 episodes were randomized to receive each treatment. Failure to respond to therapy was defined by documented or suspected bacterial infection, recurrent fever, or discontinuation of assigned therapy for any reason before neutropenia resolved. Rates of treatment failure were similar in the oral cefixime group (28%) and in the iv antibiotic group (27%; P=1.0). Results support the safety of oral cefixime therapy for low-risk febrile neutropenic children, a therapeutic approach that would facilitate earlier outpatient management and decrease the costs of treatment.lld:pubmed
pubmed-article:11112678pubmed:languageenglld:pubmed
pubmed-article:11112678pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11112678pubmed:citationSubsetIMlld:pubmed
pubmed-article:11112678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11112678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11112678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11112678pubmed:statusMEDLINElld:pubmed
pubmed-article:11112678pubmed:monthJanlld:pubmed
pubmed-article:11112678pubmed:issn1058-4838lld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:HughesW TWTlld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:FlynnP MPMlld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:SixbeyJ WJWlld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:PatrickC CCClld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:BakerD KDKlld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:SantanaV MVMlld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:HetheringtonS...lld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:RobersonP KPKlld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:SandlundJ TJTlld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:HudsonM MMMlld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:ShenepJ LJLlld:pubmed
pubmed-article:11112678pubmed:authorpubmed-author:SlobodK SKSlld:pubmed
pubmed-article:11112678pubmed:issnTypePrintlld:pubmed
pubmed-article:11112678pubmed:volume32lld:pubmed
pubmed-article:11112678pubmed:ownerNLMlld:pubmed
pubmed-article:11112678pubmed:authorsCompleteYlld:pubmed
pubmed-article:11112678pubmed:pagination36-43lld:pubmed
pubmed-article:11112678pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:meshHeadingpubmed-meshheading:11112678...lld:pubmed
pubmed-article:11112678pubmed:year2001lld:pubmed
pubmed-article:11112678pubmed:articleTitleOral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.lld:pubmed
pubmed-article:11112678pubmed:affiliationDepartment of Infectious Diseases, St. Jude Children's Research Hospital, University of Tennessee Health Sciences Center, Memphis, TN 38105, USA. jerry.shenep@stjude.orglld:pubmed
pubmed-article:11112678pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11112678pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11112678pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11112678lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11112678lld:pubmed